Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
X4 Pharmaceuticals, Inc.
arsanis.comAI Executive Summary
AI-powered analysis of 8-K filing content
X4 Pharmaceuticals appointed Kelly Gold as a Class II director effective July 1, 2026, expanding the board from five to six members. Gold brings significant finance and corporate development experience from her CFO role at CAMP4 Therapeutics, strengthening the company's governance and audit oversight.
Key Takeaways
Board expansion from 5 to 6 directors signals growth and enhanced governance capacity
Kelly Gold's CFO background at CAMP4 Therapeutics brings finance and corporate development expertise directly to X4's audit committee
2 more takeaways